Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KIF25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF200 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CAPN13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505635 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NTRK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UPK3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKNAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXD13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GYPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INSM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRTAP4-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on